Abstract
Introduction
In most clinical trials, there is much heterogeneity among individual outcomes and the treatment effect may not be the same on all of the patients. If we could determine which patients will respond better to the treatment, ideally ahead of time but also possibly soon after the treatment is administered, the development and subsequent utilization of the therapy would be dramatically improved. It is substantively interesting but challenging to identify such patient subpopulations that will derive a more pronounced benefit from the active treatment than the rest of patients. More specifically, consider a clinical trial with patients' drug response and a large number of potential predictors, such as genetic information, clinical features, and demographic information. Our objective is to develop statistical methods to select predictive covariates and consequently use them to define subpopulations with enhanced treatment effect.
With a large number of potential predictors, variable selection is often the first step in developing predictive models. There are many reasons for focusing on a subset: the desire to glean important biological insight, operational considerations for how this information can be utilized in subsequent development of the novel therapy, and the fact that a simple model has a better chance to hold in a new trial and lends itself more easily to validation efforts.
Suppose that we have a clinical response variable Y , and a set of p predictors X 1 , · · · , X p .
The problem of variable selection arises when we want to model the relationship between Y and a subset of X 1 , · · · , X p . Variable selection methods have mainly been developed for linear models. Heuristic variable selection procedures are often employed, for example, forward selection, backward elimination, and stepwise selection. A number of well-known selection criteria have been used in heuristic procedures for linear models, including AIC (Akaike, 1973) , BIC (Schwarz, 1978) , and Mallows' C p (Mallows, 1973) . More recently, regularization methods have also been used as variable selection approaches, for example, LASSO (Tibshirani, 1996) . The regularization methods conduct variable selection only in linear or parametric models. However, the linear relationship between Y and one or more predictors X is often too simple to be proper in complicated clinical data analysis. Traditional linear model does not work for detecting nonlinear patterns of the relationship between Y and X. The limitations of the linear model and other parametric statistical approaches motivate our use of nonparametric methods to model the relationship between Y and X.
The identification of subpopulation with enhanced treatment effect is recently a popular topic in clinical practice and medical research. It relates to the efforts in discovering patient-specific treatment strategy, or personalized medicine. Crump et al. (2006) conducted statistical tests for the heterogeneity of treatment effects across pre-specified patient subpopulations. Moineddin et al. (2008) proposed a multi-level random-effect model to identify subpopulations from patient baseline characteristics. Ruberg et al. (2010) and Foster et al. (2011) proposed to use a CART (Classification and Regression Tree) approach to select predictors and consequently to use their cut-off values to define subpopulations of patients.
Here we propose a method for predictive models of treatment effects using a small subset of predictors and then define a subpopulation based on the predictive models.
Our method is a combination of forward variable selection and nonparametric local regression. Forward variable selection is merely a heuristic procedure, but it is easy to implement and can obtain a subset with reasonably small prediction errors. Meanwhile, the use of nonparametric local regression has the major advantage that we make fewer assumptions about the functional form of the model for the clinical response. We intend to overcome the limitation of the existing linear models by a nonparametric approach. After we developed the method, we found that a similar idea had been suggested by Storlie and Helton (2007) but under the context of reliability analysis. Our focuses are on clinical predictive models and subpopulations. We demonstrate our variable selection approach using data simulated from a simplified yet realistic clinical trial. We also implement our method in a pharmacogenomics study of bortezomib in multiple myeloma. With a nonparametric model three predictors achieve the same prediction power as a linear model with a large number of predictors (over 100). Our method identifies patients that will derive a more pronounced benefit from a medical therapy and hence have important implications on drug development.
The structure of the paper is organized as follows: In Section 2, we define the framework of subpopulation. In Section 3, we present the detailed method of nonparametric variable selection. In Section 4, we show that the nonparametric predictive models provide consistent estimators of treatment effects when the smoothing parameters are appropriately chosen. In Section 5, we show results of a simulation study and the application to the bortezomib data set. We conclude with discussions in Section 6. Denote the sample space of X as X . A partition of X defines subpopulations of patients.
Subpopulation with Enhanced Treatment Effect
A subpopulation with an enhanced treatment effect is defined as a patient population that has a larger conditional treatment effect than the global treatment effect. Formally, the subpopulation can be represented as
Given a data set, i.e., a randomized clinical trial with n patients, we estimate E(Y trt −Y control ) by the difference of the sample means between the treatment and the control groups. We estimate the conditional expectations E(Y trt − Y control |X) by the difference of two nonparametric functions of X, one for E(Y trt |X) and the other for E(Y control |X). More specifically, we have
whereĝ trt (.) denotes the nonparametric estimate of E(Y trt |X) in the treatment group, and g control (.) denotes the nonparametric estimate of E(Y control |X) in the control group,Ȳ trt and Y control are the sample means of Y in the treatment and the control groups respectively. In our method, we estimate two predictive functionsĝ trt (.) andĝ control (.) for the treatment and the control groups respectively, instead of considering a combined response model with X plus a treatment indicator variable. Our attempt is to develop a more flexible method than the latter so that it allows completely different response models in the treatment and the control groups and each model is nonparamtric. In the following, we develop a nonparametric variable selection approach to estimate E(Y trt |X) and E(Y control |X), which provide predictive models for the response and also derives the subpopulation S. Cleveland (1979) proposed the locally weighted scatterplot smoothing (LOWESS), a local regression method for a response variable Y on a single predictor X. It was further generalized to multivariate predictors, known as LOESS (Cleveland and Devlin, 1988) , to model the relationship between a response variable Y and a set of multiple predictors,
Variable Selection via LOESS
where d is the number of predictors in the model and is often limited to four. Let y i , i = 1, · · · , n, denote n measurements of the response variable Y , and 
Forward Selection Criterion
We want to conduct forward variable selection using LOESS. Predictors are added to the model one by one if they are statistically significant. The local regression method implies
That is, the LOESS estimateĝ(x) is a linear combination of the observed response y i where l i (x) depends on the observed predictor values in a neighborhood of x, but not on y i . Let y i =ĝ(x i ) be the fitted values,ǫ i = y i −ŷ i be the residuals, and denote y = (
Since eachŷ i is a linear combination of y we havê y = Ly where L is an n × n matrix andǫ = (I − L)y where I is the n × n identity matrix.
Suppose that one predictor has been selected and L 1 y is the vector of its fitted values. We consider adding a second predictor into the model and let L 2 y be the fitted values using the two predictors. We want to test a null hypothesis H 0 of one predictor for y against an alternative hypothesis H a of two predictors using a nonparametric F -test. More specifically,
t y be the residual sum of squares of the two fits. Under H 0 , we have the following test statistiĉ
which approximately follows an F distribution with the degrees of freedom υ 2 1 /υ 2 and δ 2 1 /δ 2 , where Cleveland and Devlin, 1988 We select the first predictor by comparing a null hypothesis of a constant model to an alternative hypothesis of one predictor for Y . If the most significant single predictor has a p-value less than a cutoff, e.g., 0.01, it is added into the model. Next we consider adding a second predictor into the model. We conduct F -tests for all possible second predictors. If none of the second predictors is significant, we end with a model with only one predictor.
Otherwise, we select the most significant one and extend the model to two predictors. We continue using the nonparametric F -test as the criterion to select significant predictors and this procedure stops if no predictor is found to be significant.
Smoothing Parameter Selection
Nonparametric methods, including LOESS, use a smoothing parameter to control the amount of smoothness for the estimated function. The smoothing parameter here is the proportion of the neighbor points out of all data points that are used to fit g(x) at x. It is referred to as the span parameter α. If α is too small insufficient data fall within the neighborhood resulting in an over-fitting with large variance. On the other hand, if α is too large the local regression may not fit data well resulting in a fit with large bias. Thus the span parameter must be chosen to compromise the bias-variance trade-off.
Commonly used criteria of selecting smoothing parameters in general nonparametric techniques, e.g., smoothing splines, include AIC and Generalized Cross Validation. In our method, we use an extended version of AIC, known as AIC C . It was first introduced by Hurvich and Tsai (1989) for a linear model,
whereσ 2 is the average of residual sum of squares and d is the number of variables included in the model. Hurvich et al. (1998) further generalized AIC C to the context of nonparametric regression for smoothing parameter selection. The AIC C score for a local estimate with the smoothing parameter α is
2 is the estimated error variance and L α is the estimation matrix L as defined in Section 3.1 but depends on α. It was shown in the simulation study by Hurvich et al. (1998) that compared to the criterion of Generalized Cross Validation or AIC, the use of AIC C avoided the large variability and the tendency to undersmooth. AIC C is also easy to apply in practice since it is a function of L only through its trace.
Ideally an optimal span parameter is chosen where the AIC C score is minimized. However, it is found from our study that AIC C scores have several different patterns. For example, the reduction of AIC C scores becomes negligible near the upper boundary of the span parameter. Therefore minimizing AIC C tends to choose larger span parameters which may not be necessary. Here we define a modified criterion that selects an optimal span parameterα which is at least 0.2 and satisfieŝ
Looking for α that is the root of △AIC C = 0 is an alternative criterion to minimize AIC C .
We also study the change of AIC C , i.e., △AIC C , with large changes being favorable. In implementation, we consider a grid of the span parameter between 0.2 and 0.8, as suggested in Cleveland and Devlin (1988) , and with an increment of 0.01. We select the smallest α value in the range of 0.2 to 0.8, which either corresponds to the minimum of AIC C or the maximum change of AIC C .
This criterion defines a span parameter for a given predictor. In our variable selection procedure, we extend the criterion to a small set of multiple predictors. At the beginning of variable selection we use (1) to select an optimal span parameter for each candidate predictor
Letα 1 be the optimal span parameter for the most significant predictor at the first step. In the following steps, the span parameter is chosen to be the maximum value between 0.2 and the power ofα 1 , i.e.,α 
Predictive Model for Subpopulation
The local regression via LOESS is a kernel-type nonparametric estimator, whose properties have been extensively studied, for example, by Ruppert and Wand (1994) and Fan and Gijbels (1996) . Suppose
t is a point in R d , where we want to estimate the predictive model g(x). Given the observed data
obtain a local linear estimate of g(x) with the intercept and slope coefficients {β 0 , β 1 } as the minimum of
where K α (·) is a kernel function to weight the neighbor data around x. Analogous to LOESS, we use the tricube kernel (Cleveland and Devlin, 1988 ) in a neighborhood defined by the span parameter α. Following the general theorems of nonparametric kernel estimators (Fan and Gijbels, 1996; Ruppert and Wand, 1994) the LOESS estimator such obtained has a large sample property under regularity conditions. More specifically, with appropriately chosen α's, the LOESS estimator has both the bias and variance go to zero as the sample size n → ∞. In other words, the LOESS method provides a consistent estimate.
We fit predictive models for the treatment and the control groups separately after selecting significant predictors for these two groups respectively. Let X trt be the significant predictors for the treatment group and X control be the significant predictors for the control group. Since it is possible that either X trt or X control is ∅, the subpopulation with enhanced treatment effect can be identified in three different ways.
The subpopulation is defined as
3. Both of X trt and X control are = ∅.
Let X = (X trt , X control ). The subpopulation is defined as
Results

Simulation Results
We use data simulated from a simplified yet realistic clinical trial to demonstrate our pro- In our exploratory data analysis we find that some predictors have extreme values which may dramatically affect the model fitting. Therefore, we apply a 5IQR rule (5 times interquartile range) to detect possible outliers and exclude them from the following analysis.
For the first data set we identify X 19 as the most significant predictor in the treatment group but no significant predictor in the control group. For the simulated studies, we know the ideal subpopulations and will use the truth to assess our proposed method. As shown in Figure 2 , we identify a set of subpopulations with enhanced treatment effects according to S = {X trt ∈ X :ĝ trt (X trt ) >Ȳ trt }. Table 1 shows the prediction errors for the first data set where the identified subpopulation by our procedure is compared to the ideal subpopulation defined by X 19 > −0.22.
The subpopulation identified by our procedure has an overall accuracy of 95% (Sensitivity=94%, Specificity=95%). Table 2 shows the prediction errors for the second data set.
The identified subpopulation by our procedure is compared to the ideal subpopulation defined by X 30 > −0.42 and X 43 > −0.29. Table 2 also reports the prediction errors of the CART method by Eli Lily's group. Although we only select one predictor X 30 for the second data set, the performance of our procedure is promising with an overall accuracy of 82% (Sensitivity=94%, Specificity=70%), whereas the CART model has an overall accuracy of 83% (Sens=100%, Spec=66%). Our nonparametric method with few selected variables provides good results of subpopulations in these examples, compared to both the truth and a competing method.
Application in a Pharmacogenomics Example
We implement our method in a pharmacogenomics study of bortezomib in multiple myeloma (Mulligan et al., 2007) . Multiple myeloma is an incurable malignancy and bortezomib is the first therapeutic proteasome inhibitor tested in humans for treating relapsed multiple myeloma. As the new active agent bortezomib is a therapeutic choice in addition to the standard chemotherapy, there is a need to reliably identify the patient population that will mostly benefit from the therapy. The data set of this study is available at Gene Expression In the clinical trials, most patients (169) received the new treatment bortezomib but only 70 patients in trial 039 received chemotherapy. Therefore, in this study we focus on analysing the treatment group, i.e., the novel therapy bortezomib. The goal here is to construct predictive models for the clinical response in the treatment group, instead of comparing the treatment and the control groups. Subpopulation can be consequently defined as S = {X trt ∈ X :ĝ trt (X trt ) >Ȳ trt }, as a special case in our method.
In the exploratory study of Mulligan et al. (2007) , the five-category clinical response was simplified to two levels: progressive disease (PD) and response (R), excluding no change (NC)
patients. Since the data is high dimensional with 44,928 genes but 264 patients, they applied a two-stage gene filtering method in which only the 9200 gene probe sets with the strongest between-sample variance relative to their in-sample replicate variance were retained. Among the 9200 genes only the top 100 differentially expressed genes with respect to clinical response (PD vs. R) by t-tests were used as predictors in the predictive model. The data were also divided into a training data set for trials 025 and 040, and a test data set for trial 039. A linear predictor classifier (Wright et al., 2003) was developed on the training data and was used to classify each patient to be either PD or R in the test data. The classifier is based on a linear combination of the 100 predictors with each being weighted by its t-test score.
In our S27a, is a component of the 40S subunit of the ribosome. Identification of these genes provides a hint for further studies in myeloma and the treatment effect of bortezomib. They will also be used to define subpopulations that benefit from bortezomib.
A predictive model with the three genes is fitted by LOESS. The span parameter is chosen to be 0.8 at the first step of the variable selection according to AIC C . The span parameter is about 0.6, as the square of 0.8, at the second step and 0.5 (0.8 3 = 0.512) at the third step.
The predictive model is used to predict patient response in the test data. If the predicted clinical response value is less than or equal to 2 it is classified as nonresponse (NR), which includes both PD and NC, otherwise it is classified as response (R), which includes MR, PR and CR.
[ Figure 3 about here.]
[ Table 4 Table 3 . In summary, we identify 37 out of the 38 patients who are responders to the bortezomib treatment and only one patient, who is a responder to the treatment, is incorrectly classified as progressive disease (PD). Two out of the 15 patients who have PD to the treatment are correctly classified, but the other 13 patients are incorrectly classified as responders to the treatment. The overall accuracy of our prediction result is 74%, which is comparable to 75% of Mulligan et al.
(2007)'s result. Thus, with a nonparametric model a small number of predictors can achieve the same prediction power as linear model with a much larger number of predictors (100).
Applying our model to a new patient our model will predict whether or not it has a more pronounced benefit from the bortezomib treatment.
Discussion
In this paper we perform a nonparametric forward variable selection procedure to identify significant predictive covariates among a large set of potential predictors which may include standard clinical and laboratory features and whole genome gene expression measurements.
Forward variable selection is merely a heuristic procedure but it has the advantage of easy implementation in practice. It is not limited by high dimensional predictors because it starts with a constant model with only an intercept and will end up with selecting a small number of significant predictors. The local regression method, LOESS, is computationally efficient, especially when we consider a small number of significant predictors (≤ 4). In practice we recommend checking for outliers before doing any analysis. We also need to pay attention to fitting a local regression in the boundary of data. While local linear regression has been shown to provide a simple and effective way of modeling slopes in the boundary region and reduce bias compared with other kernel estimates (e.g., Nadaraya-Watson estimate) (Hastie and Loader, 1993) , the mean squared error of the local linear regression may still be big when data are sparse and of high curvature in the boundary. Fortunately, the boundary effect is not severe in our examples. In general, visualization of the data and their LOESS fitting in the boundary is always recommended.
While variable selection helps to build a predictive model based on a small number of significant predictors, an alternative approach is to consider that interesting features of high-dimensional data are retrievable from low-dimension projections. Exploring dimension reduction techniques in analysis of high dimensional but low sample size data is one of our future works.
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